Fundraising FoxDelaware Crossing Investor Group
Angel networkPhiladelphia · Seed–Series A · 5 people tracked
Find your way into Delaware Crossing Investor Group
Each arrow is one introduction. Sign up to fill in the first one.
Ask Bill Frist to introduce you to Antonio Tedesco
You →Bill · together at Accolade, Inc. →Antonio
Ask Jamie Chen to introduce you to Elizabeth Sigety
You →Jamie · together at Delaware Crossing Investor Group →Elizabeth
Ask Sam Okafor to introduce you to Jeffrey Nicholas
You →Sam · together at BD →Jeffrey
- Dick Woodbridge56 people can intro you
- Michael Cirafesi2 people can intro you
Sign up to find every way you can get introduced to Delaware Crossing Investor Group
- Your email: who you already know at Delaware Crossing Investor Group, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Delaware Crossing Investor Group team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
DCIG is an angel investor network serving entrepreneurial and investor communities on both sides of the Delaware River across the Greater Philadelphia and broader Mid-Atlantic region. Members contribute both investment capital and industry expertise, backing early-stage and growth-oriented companies across a wide range of industries. During screening, the group weighs factors such as management team strength, growth prospects, competitive market dynamics, and the business model. DCIG acknowledges these investments carry high risk but offer the potential for high returns, and it emphasizes shared due diligence with subject-matter experts. The group holds regular monthly membership and screening committee meetings and offers virtual participation to source deals throughout the region.
Source: firm website, verified Sep 27, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 29 of 71 portfolio companiesHealthtech ×13Biotech ×12Medical Devices ×8SaaS ×7AI & Machine Learning ×4Deep Tech ×4Fintech ×4Advanced Manufacturing ×3
HQs:United States×26
Who they back
founder profiles across 17 portfolio companiesFounding team size:solo founder×112 founders×53 founders×1
Where their founders studiedfrom 13 founders with education data
Ohio University ×2The Tuck School of Business at Dartmouth ×2
What their founders studiedfrom 12 founders with field-of-study data
Life Sciences ×4Economics ×3Finance & Accounting ×3Chemistry ×2
Accelerator rootsportfolio companies that came through a program
Investments · 71 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22021 · 22018 · 22017 · 12012 · 210 dated
Immunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer.
BiotechHealthtechExton, US
Scott K. Dessain(Executive Officer, Director)inDennis H Giesing(Executive Officer)inCorleen Roche(Executive Officer)inMichael J Morin(Executive Officer)Purnanand Sarma(Executive Officer, Director)inGeorge Hobbs(Executive Officer)
Co-investorsBioAdvanceEvolution VC PartnersMilitia Hill VenturesPivotal Life SciencesRobin Hood VenturesT. Rowe Price
AcademyOne builds SaaS tools and automated workflows that help colleges, universities, and governance organizations manage enrollment, academic credit portability, and degree completion.
EdTechSaaS
CytoAgents is a clinical-stage biopharmaceutical company developing therapies for the life-threatening symptoms of Cytokine Release Syndrome (CRS), an immune overreaction causing systemic inflammation.
BiotechHealthtechPittsburgh, US
Teresa Whalen, RPh(Chief Executive Officer)inCatherine Mott(Director)Teresa Whalen(Chief Executive Officer)Anthony McCarley(Director)John Friedman(Director)Stanley Marks(Director)
Co-investorsBoston Harbor AngelsRichard King Mellon Foundation
GILSON Snow designs and handcrafts snowboards and skis in the USA using locally sourced Pennsylvania Poplar, building custom gear on demand for individual riders.
Advanced ManufacturingConsumerDirect to ConsumerSports TechSelinsgrove, US
Austin Royer(Co-founder)Nicholas Gilson(Founder)Andrew Mikowski(Executive Officer, Director)Adam Vanderhyden(Executive Officer, Director)Samantha Ginsberg(Director)David Johnson(Director)
Co-investorsWhite Rose VenturesKeystone Innovation
Grassroots Unwired provides mobile-first canvassing and field-organizing technology for political campaigns and nonprofit organizations, supporting voter outreach, fundraising, and constituent data capture.
FintechGovTechImpact & Social GoodSaaSYardley, US
RUSS OSTER(CEO)in
Co-investorsBen Franklin Technology PartnersBullpen CapitalRobin Hood Ventures
Holganix makes Bio 800+ soil products containing over 800 species of beneficial microorganisms that improve soil health, allowing farmers and turf professionals to reduce fertilizer and water use while increasing crop yields and carbon capture.
AgTechCleantechClimate TechImpact & Social GoodGlen Mills, US
Barrett Ersek(Founder & CEO)inGene Godick(Executive Officer)Bryan Hansel(Head of Revenue Strategy)inDavid Stark(Executive)inKaitlyn Ersek(Chief of Staff)inRadhika Moolgavkar(Vice President HGX, Product)in
Co-investorsAg Ventures AllianceArgonautic VenturesiSelect FundJumpStart New Jersey Angel NetworkCultivation Capital
Honeycomb Credit runs an investment crowdfunding platform where individuals can invest in local small businesses, such as breweries, restaurants, and shops, in exchange for potential returns.
FintechImpact & Social GoodMarketplacesPittsburgh, US
George Cook(Co-founder & CEO)inKen Martin(Founder)inMathias Jamora(CFO)inChristian Bilger(Executive Officer)Edward Engler(Director)
Co-investorsAmerican Family Insurance Institute for Corporate and Social ImpactCitta CapitalMudita VentureSustainVCSymphonic Capital3 Points Rising Ventures+2 more
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioAdvanceBioGenerator VenturesMaryland TEDCONYBC VenturesOld Line Capital PartnersTEDCO+1 more
LUXTECH manufactures LED modules for luminaire producers, enabling them to create globe illumination with single modular components.
Advanced ManufacturingCleantechHardwarePhiladelphia, US
Co-investorsBroad Street AngelsRobin Hood Ventures
Measure is a social media analytics platform for brand teams managing accounts across markets, agencies, and product lines.
AdTechAI & Machine LearningMarketing TechMedia & EntertainmentSaaSChalfont, US
Thomas Kramer(Executive Officer, Director)
BoardJames Creech(Director)inDan Zitting(Director)
Co-investors37 AngelsKern Venture GroupRobin Hood Ventures
Medcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion.
BiotechHealthtechMedical DevicesRiverdale, US
Jim Buck(President, CEO & Director)inMatthew Dowling, Ph.D(Dr. Dowling is the Chief Scientic Officer of the Issuer.)Rich Vincent(Mr. Vincent is the Chief Financial Officer of the Issuer.)Larry Tiffany(Mr. Tiffany is the Executive Chairman of the Issuer.)inPeter Thomas(Executive Officer, Director)Matthew Dowling(Executive Officer, Director)
Co-investorsAspira CapitalMaryland TEDCORobin Hood VenturesTEDCO
Dealum provides software tools for business angel networks and investor groups to manage operations, collaborate, and streamline deal-making processes.
Enterprise SoftwareFintechSaaS
Rain Kivisik(Founder)
Co-investorsAggie Angel NetworkAngel ForumBusiness Angels Club Berlin-Brandenburg e.V.Central Texas Angel NetworkDakar Network Angels (DNA)DanBAN+14 more
Nicklpass provides a platform for organizations to centralize the management, governance, and purchasing of digital tools and SaaS subscriptions across their teams.
Cloud ComputingCrypto & Web3Developer ToolsEnterprise SoftwareSaaSBrooklyn, US
Co-investorsDigital Currency GroupGreen Egg VenturesHustle FundReign VenturesRiverPark VenturesSixty8 Capital+2 more
Ophidion is an early-stage CNS biopharmaceutical company developing a non-invasive carrier technology that delivers gene-silencing agents and other therapeutics across the blood-brain barrier into the brain.
BiotechDeep TechHealthtechBethlehem, US
Julie Miwa(Director, Promoter)inYacoub Habib(Executive Officer, Director, Promoter)
BoardMichael Lark(Director)Scott Fishman(Director)Claudine Bruck(Director)
Co-investorsEisai Innovation, Inc.Robin Hood Ventures
BiotechKennett Square, US
Frank Minella(Executive Officer, Director)inAlexander Ruckdaeschel(Executive Officer, Director)
BoardJohn H. Stewart(Director)Andrew Koopman(Director)
Co-investorsItalian Angels for GrowthNYU Innovation Venture Fund
HealthtechAmbler, US
Tessie McNeely(Executive Officer, Director)inAdam Dakin(Executive Officer, Director)inMark Evan Schafer(Executive Officer, Director)
BoardMichael Wells(Director)
Doylestown, US
Jose Plehn-Dujowich(Executive Officer, Director)Kevin Sheetz(Executive Officer, Director)GEORGE A. MOSSMAN(Director)KENNETH DALY(Director)JANICE BURG-LEVI(Director)ROBERT KEITH(Director)
Co-investorsTribeca Early Stage PartnersBrewer Lane Ventures
Reflexion builds hardware devices and web-based software for cognitive training and tracking, using large touch-screen displays that measure and train functions like reaction time, decision-making, and short-term memory.
AI & Machine LearningHardwareHealthtechSports Tech
Co-investors1855 Capital PartnersInspovation VenturesSonder CapitalWhite Rose Ventures
Saladax Biomedical develops blood-level tests that help psychiatrists and oncologists determine correct individual drug dosages based on patient metabolism, supporting treatment decisions and reducing toxicity risk.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsExcel Venture ManagementLife Sciences Greenhouse InvestmentsGolden Seeds
Sauvie is developing a protein discovery platform in the biological intelligence space.
AI & Machine LearningBiotechDeep Tech
Co-investorsRobin Hood Ventures
Seamless is a revenue operations platform that uses AI to automate sales outreach and contact verification for sales, marketing, and customer success teams.
AI & Machine LearningSaaSSales TechWorthington, US
Brandon Bornancin(Founder)inDanielle Demming(Founder)in
Co-investors9Mile LabsBreak Trail VenturesNewark Venture Partners
Seneca Therapeutics develops oncolytic virus immunotherapies, particularly Seneca Valley Virus (SVV-001), for treating aggressive and therapy-resistant solid cancers.
BiotechDeep TechHealthtechMedical DevicesBlue Bell, US
Paul L. Hallenbeck(Founder, President and Chief Scientific Officer)inCuong Do(Executive Officer, Director)inJames Hussey(Executive Officer, Director)in
BoardMark Kerschner(Director)
Co-investorsBroad Street AngelsDellin InvestmentsKeiretsu ForumNW Angel
Sporttrade is a sports betting platform that modernizes the industry using proprietary technology and capital markets expertise, operating with a focus on equity, responsibility, and accessibility.
B2B MarketplacesFintechSports TechUnionville, US
Alexander Kane(Executive Officer, Director)inAnthony(Chief Financial Officer)Arpita(Chief Compliance Officer)Thomas Wittman(Director)David Frohardt-Lane(Director)
Co-investorsAcies InvestmentsBelvedere Strategic CapitalTechstarsImpression VenturesJump CapitalNasdaq Ventures
SunRay Scientific develops anisotropic conductive adhesives (ZTACH ACE), conductive inks, epoxies, and related materials for printed and flexible electronics, integrable with existing pick-and-place manufacturing equipment.
Advanced ManufacturingHardwareNew MaterialsWall Township, US
Andrew Stemmermann(CTO, Co-Founder)inMadhu Stemmermann(CEO, Co-Founder)in
BoardSteve Socolof(Director)in
Co-investorsBroad Street AngelsCentral Texas Angel NetworkJumpStart New Jersey Angel NetworkSoundboard Venture FundWestchester AngelsGolden Seeds+1 more
Thrombolex develops endovascular catheters using pharmaco-mechanical technology to treat arterial and venous thromboembolic (A+VTE) conditions by dissolving blood clots.
BiotechHealthtechMedical DevicesKingston, US
Riyaz Bashir(Innovator / Creator of BASHIR Endovascular Catheters)John Cerminaro(Executive Officer)inMichael J. Cerminaro(Executive Officer, Director)inMarvin Woodall(Executive Officer, Director)Brian G. Firth(Executive Officer, Director)Todd Richmond(Director)
Co-investorsOrbiMed
Thubrikar Aortic Valve is a medical device company developing a transcatheter aortic valve (the Optimum TAV) focused on valve durability, aimed at clinicians treating aortic valve disease.
HealthtechMedical DevicesBoston, US
Mano Thubrikarin
TicketLeap is an online event ticketing platform that lets organizers create accounts and sell event tickets, with mobile-optimized event management tools.
MarketplacesMedia & EntertainmentSaaSPhiladelphia, US
Stanchak Christopher(Executive Officer, Director)Tim Raybould(Executive Officer)in
BoardPeter Albert(Director)James Thompson(Director)Michael Aronson(Director)inColin Evans(Director)in
Co-investorsBeacon AngelsRobin Hood VenturesBen Franklin Technology Partners
Trace Orthopedics is developing a device and technique (the Trace Method) to repair partially torn tendons back to bone through a needle inserted through the skin, avoiding open or arthroscopic surgery and general anesthesia.
HealthtechMedical DevicesPhiladelphia, US
William B. Morrison(Co-Founder & Medical Director)Adam Greenspan(President & CEO)
Co-investorsCentral Texas Angel Network
Vytala is a foodtech company that develops nutrition solutions to address fat malabsorption and other nutrient deficiencies.
BiotechDigital HealthFoodTechHealthtechMedical Devices
Jim O'Connell(CEO and Founder)in
Co-investorsRobin Hood VenturesThe MBA FundUlu Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AnglrAnnovis BioBambuBarkly PetsBiologics MDBridge SemiconductorCEPHEACompliance Assurance CorporationEdge TherapeuticsEvrys BioFinancial TrackingFuegoGenproHulafrogLiaLuxtexhMoreBankMyotaNanoPackNextStage CapitalNoviraOnlySky, Inc.Oral BiolifePervasive Group’s MMGuardianPledgeITPreclickReliefbandSequenomSmartStructuresSnowvationSocial LadderSonnest, IncSquareknotStabilizOrthoStarrStoopStradosThruPoreThruPore TechnologiesToblyUnirisxZive
Exits · 2
1 IPOs · 1 acquisitionsImmunomeNASDAQ: IMNMEdge Therapeuticsacq. by PDS Biotechnology Corp.
Portfolio news
latest coverage across their companiesImmunome · stocktitan.net · Aug 14, 2026
CytoAgents · finance.yahoo.com · Oct 1, 2025
Seneca Therapeutics, Inc Biotechnology · senecatherapeutics.com · Sep 5, 2025
Frequently asked questions
- How many investments has Delaware Crossing Investor Group made?
- Delaware Crossing Investor Group has 71 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does Delaware Crossing Investor Group invest at?
- Delaware Crossing Investor Group invests at the Seed, Series A stages.
- What sectors does Delaware Crossing Investor Group focus on?
- Delaware Crossing Investor Group focuses on AI & Machine Learning, Biotech, Enterprise Software, Fintech, Healthtech, Medical Devices, Sector Agnostic.
- Where is Delaware Crossing Investor Group located?
- Delaware Crossing Investor Group is headquartered in Philadelphia, US.
- Who does Delaware Crossing Investor Group co-invest with?
- Delaware Crossing Investor Group most often shares deals with Robin Hood Ventures, Broad Street Angels, Central Texas Angel Network, among 84 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Qiming Venture Partners (启明创投) is a China-focused venture capital firm that invests in and supports early- and growth-stage technology and healthcare companies, providing capital, industry resources, and strategic guidance through milestones such as financing, IPOs, and M&A.
Colle Capital Partners is an opportunistic, early-stage technology venture fund investing globally across a broad range of technology sectors.
MPG Fund is an early-stage venture investor backing technology startups.